Abstract

Objective To approach the function of JAM-1 in corneal endothelium by observing cornea endothelium structure and activity change induced by antibody blockage. Methods Twenty-eight corneas were obtained from 14 rats and were divided into two groups. Corneas of the right eye were in experiment group and processed with monoclonal antibody of JAM-1 to block the function of JAM-l; corneas of the left eye were in control group and processed with PBS buffer. All corneas were cultured in DMEM with high glucose for 5 days and then dehydrated in DMEM containing 5% dextran-T500 for 24 hours. Twelve corneas of each group were underwent Trypan blue - alizarin vital staining and cornea thickness were measured. Two corneas of each group and other 2 flesh normal corneas were fixed with 4% glutaraldehyde for transmission electron microscopy. Results The active cell counting of experiment group and control group were (2008± 505)/mm2 and (934±521)/mm2 respectively, P 〈0.01. The cornea thickness of the two groups were (375.02± 83.33)1.1 m and (461.814±39.14)p m respectively, P 〈0.01. Transmission electron microscopy showed that in experiment group the endothelium cell appeared more ultrastructural damage and autophagosome formation. Conclusions JAM-l, as a component of cell junctions, its function is essential for corneal endothelium structure and activity in tissue culture preservation. Key words: JAM-l; Tissue culture preservation; Vital staining; Transmission electron mi-croscopy

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.